Colgate-Palmolive Company

πŸ‡ΊπŸ‡ΈNew York Stock Exchange
Back to all articles
Slightly Bullish +25

Has The Recent Pullback Opened An Opportunity In Colgate-Palmolive (CL)?

πŸ“‰ Colgate-Palmolive (CL) has seen a share price decline of 4.2% over the last week and 10.5% over the past month.

πŸ’° The current stock price is approximately US$85.12, while year-to-date returns remain positive at 9.6%.

πŸ“Š Long-term performance shows a 3-year return of 24.5% and a 5-year return of 20.9%.

βš–οΈ Simply Wall St's valuation checks give Colgate-Palmolive a score of 2 out of 6 based on their methodology.

πŸ’΅ A Discounted Cash Flow (DCF) analysis estimates an intrinsic value of about US$125.40 per share.

πŸ“‰ This implies the stock is trading at roughly a 32.1% discount compared to its DCF estimate.

πŸ”’ Colgate-Palmolive currently trades at a P/E ratio of 32.0x.

🏭 This P/E is higher than the industry average of 16.4x and the peer group average of 22.1x.

🎯 Simply Wall St's proprietary Fair Ratio for the company is set at 27.8x earnings.

✍️ The article suggests using "Narratives" to connect personal investment stories with financial numbers for valuation.

πŸ“ˆ Analyst targets range from US$83 to US$106, allowing investors to model different future scenarios.

πŸ›‘οΈ Colgate-Palmolive is described as a large, globally recognized household products brand managing cost and competition.

⚠️ The article notes that recent weakness may be due to investors reassessing risk regarding consumer demand trends.

πŸ“ Simply Wall St provides fundamental analysis driven by historical data and analyst forecasts only.

🚫 The report explicitly states it is not financial advice and does not constitute a recommendation to buy or sell.

🌐 The company operates in the Household Products sector with a focus on cost management and emerging markets.

πŸ“‰ Recent coverage highlights attention on managing costs, competition in oral care, and broader consumer demand.

Bullish Signals
  • Colgate-Palmolive's share price has recovered to a 9.6% year-to-date return despite recent short-term volatility, indicating underlying stability over longer periods of 24.5% (3-year) and 20.9% (5-year).
  • A Discounted Cash Flow model estimates an intrinsic value of US$125.40 per share, suggesting the current price of around US$85.12 represents a significant 32.1% discount to fair value.
  • The company is projecting free cash flow growth from $3.58 billion in the latest twelve months to an estimated $4.10 billion by 2030 based on analyst inputs and Simply Wall St extrapolations.
  • The current P/E ratio of 32.0x reflects a premium valuation compared to the industry average of 16.4x, which aligns with the company's strong growth prospects and market leadership as a globally recognized household brand.
Risk Factors
  • Colgate-Palmolive trades at a P/E ratio of 32.0x, which exceeds its proprietary Fair Ratio estimate of 27.8x and the industry average of 16.4x, suggesting the stock is priced on a multiple that analysts may not fully support.
  • Analyst consensus targets range from as low as $83 to $106, indicating significant uncertainty and disagreement among professionals regarding the company's fair value compared to the current price of around $85.12.
  • Recent coverage highlights risks such as rising costs, intensifying competition in oral care, and cautious consumer demand trends, which could pressure future revenue growth and margin expansion plans.
  • While a Discounted Cash Flow model estimates an intrinsic value of $125.40 based on 2030 projections, this valuation relies heavily on assumptions about future cash flow reaching $4.10b by 2030, leaving the stock vulnerable if cost programs or growth in emerging markets fail to materialize.
Full Analysis
Colgate-Palmolive (CL) shares have experienced a recent price pullback, declining 4.2% over the last week and 10.5% in the past month, despite posting a year-to-date return of 9.6%. Simply Wall St presents this dip as a potential entry opportunity for investors seeking to evaluate whether the stock is fairly priced or undervalued at approximately US$85.12. Valuation analysis provided by Simply Wall St assigns the company a score of 2 out of 6 based on its internal checks. A Discounted Cash Flow (DCF) model, utilizing a 2 Stage Free Cash Flow to Equity approach and projecting free cash flow growth from recent levels of US$3.58 billion to US$4.10 billion by 2030, calculates an intrinsic value of US$125.40 per share. This figure represents roughly a 32.1% discount to the current trading price on the cash flow view. However, the P/E ratio analysis suggests a different picture regarding traditional multiples. Colgate-Palmolive currently trades at a Price-to-Earnings ratio of 32.0x, which is significantly higher than the industry average of 16.4x for Household Products and the peer group average of 22.1x. The company's proprietary Fair Ratio model estimates a fair P/E multiple of 27.8x, implying that based on earnings alone, the stock trades at a richer multiple than justified by its growth prospects and risks. Simply Wall St concludes that while the cash flow model indicates undervaluation, the P/E suggests a premium valuation, recommending investors use "Narratives" to synthesize these conflicting signals with their own assumptions about future revenue, margins, and market conditions.